REHAB Fontan Failure: A Trial of Cardiac Rehabilitation

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to compare the impact of cardiac rehabilitation on Fontan failure patients' exertional tolerance, frailty, and quality of life. 1. Among patients with Fontan failure, will cardiac rehabilitation increase average daily steps compared to usual care? 2. Among patients with Fontan failure, will cardiac rehabilitation improve exertional tolerance (as measured by cardiopulmonary exercise testing), frailty, and self-reported quality of life metrics compared to usual care?

Clinical Trial Description

REHAB Fontan Failure is a a multi-center, non-blinded, randomized clinical trial evaluating the effect of cardiac rehabilitation compared to usual care on exercise tolerance among adults with Fontan failure. Eligible study subjects will be identified from clinical chart review and study informational fliers will be sent to Adult Congenital Heart Disease (ACHD) cardiologists at all centers. Fontan failure patients being evaluated for outpatient care at ACHD centers and meeting eligibility criteria will be enrolled and randomly assigned to either cardiac rehabilitation or usual clinical care. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06150950
Study type	Interventional
Source	Stanford University
Contact
Status	Recruiting
Phase	N/A
Start date	May 5, 2024
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03119090` - Fontan Imaging Biomarkers (FIB) Study
Completed	`NCT05063903` - Exercise Capacity in Patients With Fontan Procedure
Not yet recruiting	`NCT04017494` - Validation of Cardiac Magnetic Resonance Sequences in Patients With Single Ventricles
Recruiting	`NCT04106479` - NIRS in Congenital Heart Defects - Correlation With Echocardiography
Completed	`NCT03481985` - The Effect of Fontan Fenestration Closure on Hepatic Stiffness
Completed	`NCT03088345` - Early Use of Vasopressin in Post-Fontan Management	Phase 2/Phase 3
Completed	`NCT03470428` - Clinical Characteristics and Associations of the "Good Fontan" Patient
Completed	`NCT04956952` - Enhanced External Counterpulsation in Patients With Fontan Circulation	N/A
Completed	`NCT04785482` - The PaTHS Descriptive Correlational Longitudinal Study
Not yet recruiting	`NCT06434207` - Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
Withdrawn	`NCT03997097` - Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Disease	Phase 3
Completed	`NCT05118152` - Correlation Between 3D Echocardiography and Cardiopulmonary Exercise Testing in Patients With Single Ventricle
Recruiting	`NCT05262907` - Ventripoint Single Ventricle Study	N/A
Withdrawn	`NCT01149603` - The Destination Therapy Evaluation for Failing Fontan Study	N/A
Recruiting	`NCT04467671` - Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts	Phase 2
Completed	`NCT03339466` - Inspiratory Muscle Therapy in Subjects With Fontan Circulations	N/A
Completed	`NCT05011565` - Hemodynamic, Vascular and Muscular Parameters of Exercise Capacity in Single-Ventricle Patients With Fontan Procedure
Active, not recruiting	`NCT03263312` - Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient	N/A
Recruiting	`NCT05034354` - Virtual Remote Physiological Monitoring Program of Children With Heart Disease	N/A
Completed	`NCT04613934` - Redesigning the Care Journey of Patients With Single-ventricle Congenital Heart Disease